ci 934 has been researched along with cefuroxime in 1 studies
Studies (ci 934) | Trials (ci 934) | Recent Studies (post-2010) (ci 934) | Studies (cefuroxime) | Trials (cefuroxime) | Recent Studies (post-2010) (cefuroxime) |
---|---|---|---|---|---|
33 | 0 | 2 | 2,313 | 517 | 502 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Finch, R; Martin, J; Pilkington, R | 1 |
1 other study(ies) available for ci 934 and cefuroxime
Article | Year |
---|---|
In vitro assessment of CI-934--a new quinolone derivative.
Topics: Anti-Bacterial Agents; Cefotaxime; Cefuroxime; Ciprofloxacin; Enoxacin; Erythromycin; Fluoroquinolones; Gentamicins; Kinetics; Naphthyridines; Quinolines; Streptococcus; Streptococcus pneumoniae; Vancomycin | 1986 |